Sonnet Biotherapeutics HoldiSONN
13F holders, Q4 2025 (December 31)1holders −26
1new positions
27sold out
$4.58avg. 13F price*
At the end of Q4 2025, 1 institutions reported holding Sonnet Biotherapeutics Holdi (SONN) in their 13F filings, down 26 from Q3 2025. 1 opened new positions and 27 sold out. The largest holder was Formidable Asset Management, LLC ($170K).
- Company
- Sonnet Biotherapeutics Holdi
- CUSIP
- 83548R402
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $170K |
| Exits | 27 | $3.5M |
All 13F filers, Q3 2025 → Q4 2025: 37,185 shares bought and 771,098 shares sold, net −733,913 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Formidable Asset Management, LLC | 0.02% | New | 37,185 | $170K |
"% of holder's portfolio" is SONN's weight in each manager's 13F, not the share of Sonnet Biotherapeutics Holdi the manager owns.